×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PBH – prestige consumer healthcare inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PBH
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/9
08:00 am
pbh
Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation
Low
Report
Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation
1/7
02:04 am
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
1/6
08:17 am
pbh
Prestige Consumer Healthcare expands CFO Christine Sacco’s role to include COO responsibilities [Seeking Alpha]
Low
Report
Prestige Consumer Healthcare expands CFO Christine Sacco’s role to include COO responsibilities [Seeking Alpha]
1/6
08:00 am
pbh
Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco’s Role to Include Chief Operating Officer Responsibilities
Low
Report
Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco’s Role to Include Chief Operating Officer Responsibilities
12/30
11:34 pm
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
12/21
07:52 am
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at Raymond James to a "moderate buy" rating.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at Raymond James to a "moderate buy" rating.
12/18
11:06 pm
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
12/10
11:01 pm
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2024
06:00 am
pbh
prestige consumer healthcare inc.
IN-LINE
Report
3.2%
prestige consumer healthcare inc.
8/8/2024
06:00 am
pbh
prestige consumer healthcare inc.
BEAT
Report
-3.1%
prestige consumer healthcare inc.
5/14/2024
05:00 pm
pbh
prestige consumer healthcare inc.
MISS
Report
-3.9%
prestige consumer healthcare inc.
2/8/2024
06:00 am
pbh
prestige consumer healthcare inc.
BEAT
Report
8.4%
prestige consumer healthcare inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/7
04:06 pm
pbh
Form 4 Prestige Consumer Health For: Jan 06 Filed by: Sacco Christine
Low
Report
Form 4 Prestige Consumer Health For: Jan 06 Filed by: Sacco Christine
1/6
08:00 am
pbh
Form 8-K Prestige Consumer Health For: Jan 06
Low
Report
Form 8-K Prestige Consumer Health For: Jan 06
12/10
04:01 pm
pbh
Form 4 Prestige Consumer Health For: Dec 06 Filed by: P'Pool William
Low
Report
Form 4 Prestige Consumer Health For: Dec 06 Filed by: P'Pool William
11/21
04:02 pm
pbh
Form 4 Prestige Consumer Health For: Nov 19 Filed by: Lombardi Ronald M.
Low
Report
Form 4 Prestige Consumer Health For: Nov 19 Filed by: Lombardi Ronald M.
11/19
04:13 pm
pbh
Form 144 Prestige Consumer Health Filed by: Lombardi Ronald M.
Low
Report
Form 144 Prestige Consumer Health Filed by: Lombardi Ronald M.
11/19
04:01 pm
pbh
Form 4 Prestige Consumer Health For: Nov 18 Filed by: Lombardi Ronald M.
Low
Report
Form 4 Prestige Consumer Health For: Nov 18 Filed by: Lombardi Ronald M.
11/18
05:16 pm
pbh
Form 144 Prestige Consumer Health Filed by: Lombardi Ronald M.
Medium
Report
Form 144 Prestige Consumer Health Filed by: Lombardi Ronald M.
11/14
07:43 pm
pbh
Form 4 Prestige Consumer Health For: Nov 12 Filed by: P'Pool William
Low
Report
Form 4 Prestige Consumer Health For: Nov 12 Filed by: P'Pool William
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/26
Prestige Consumer Healthcare Inc (NYSE: PBH) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating.
14.3%
3/23 Prestige Consumer Healthcare Inc (NYSE: PBH) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "market perform" rating on the stock. 9.7%
2/6 Q3/2020 12/31/2019 EPS 0.810 ZacksConsensus 0.750 ActVsEst 0.060 - Beat 8.4%
11/1 Prestige Consumer Healthcare's (PBH) CEO Ron Lombardi on Q2 2020 Results - Earnings Call Transcript [Seeking Alpha] 6.1%
3/2 Form 8-K Prestige Consumer Health For: Mar 02 4.9%
3/18 Prestige Consumer Healthcare Inc (NYSE: PBH) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. 4.4%
11/1 Prestige Consumer Healthcare Inc (PBH) Q2 2020 Earnings Call Transcript [The Motley Fool] 4.1%
4/27 Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Fourth Quarter and Year-End Earnings Results 3.1%
5/9 Q4/2019 3/31/2019 EPS 0.720 ZacksConsensus 0.700 ActVsEst 0.020 - Beat 2.7%
12/16 Prestige Consumer Healthcare Inc (NYSE: PBH) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating. 2.5%
3/23 Prestige Consumer Healthcare Inc (NYSE: PBH) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "market perform" rating on the stock. 9.7%
2/6 Q3/2020 12/31/2019 EPS 0.810 ZacksConsensus 0.750 ActVsEst 0.060 - Beat 8.4%
11/1 Prestige Consumer Healthcare's (PBH) CEO Ron Lombardi on Q2 2020 Results - Earnings Call Transcript [Seeking Alpha] 6.1%
3/2 Form 8-K Prestige Consumer Health For: Mar 02 4.9%
3/18 Prestige Consumer Healthcare Inc (NYSE: PBH) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. 4.4%
11/1 Prestige Consumer Healthcare Inc (PBH) Q2 2020 Earnings Call Transcript [The Motley Fool] 4.1%
4/27 Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Fourth Quarter and Year-End Earnings Results 3.1%
5/9 Q4/2019 3/31/2019 EPS 0.720 ZacksConsensus 0.700 ActVsEst 0.020 - Beat 2.7%
12/16 Prestige Consumer Healthcare Inc (NYSE: PBH) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating. 2.5%
TOP News Decliners
4/14
Prestige Consumer Healthcare Inc (NYSE: PBH) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating.
-4.9%
2/8 Prestige Consumer Healthcare Inc (NYSE: PBH) had its "neutral" rating re-affirmed by analysts at DA Davidson. -4.6%
5/12 Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -3.0%
9/13 Form 4 Prestige Consumer Health For: Sep 12 Filed by: Sacco Christine -2.9%
8/1 Prestige Consumer Healthcare Inc. Reports Fiscal 2020 First Quarter Results -2.8%
8/3 Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] -2.8%
1/6 Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Third Quarter Earnings Results -2.7%
11/15 Prestige Consumer Healthcare Inc. Announces Pricing of $400 Million Senior Notes -2.5%
12/31 Prestige Consumer Healthcare Inc (NYSE: PBH) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $44.00 price target on the stock. -1.7%
4/15 Prestige Consumer Healthcare Inc (NYSE: PBH) had its price target raised by analysts at DA Davidson from $43.00 to $47.00. -1.6%
2/8 Prestige Consumer Healthcare Inc (NYSE: PBH) had its "neutral" rating re-affirmed by analysts at DA Davidson. -4.6%
5/12 Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -3.0%
9/13 Form 4 Prestige Consumer Health For: Sep 12 Filed by: Sacco Christine -2.9%
8/1 Prestige Consumer Healthcare Inc. Reports Fiscal 2020 First Quarter Results -2.8%
8/3 Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] -2.8%
1/6 Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Third Quarter Earnings Results -2.7%
11/15 Prestige Consumer Healthcare Inc. Announces Pricing of $400 Million Senior Notes -2.5%
12/31 Prestige Consumer Healthcare Inc (NYSE: PBH) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $44.00 price target on the stock. -1.7%
4/15 Prestige Consumer Healthcare Inc (NYSE: PBH) had its price target raised by analysts at DA Davidson from $43.00 to $47.00. -1.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: